IFA treatment facilitated host immune clearance of hypervirulent <i>K</i>. <i>pneumoniae</i> by targeting capsule. by Tingting Wang (123983)

IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia. by Tingting Wang (123983)

IFA reduced the virulence of hypervirulent <i>K</i>. <i>pneumoniae</i> in <i>G</i>. <i>mellonella</i> larvae. by Tingting Wang (123983)

The effect of IFN-β and Vit D on the IL-1β expression. by Farzad Nasri (8941850)

“…In the co-treatment groups, a significant dose-dependent decrease was seen in the IL-1β expression <b>(C)</b>. …”

IFA reduced the capsular biosynthesis through altering bacterial metabolism. by Tingting Wang (123983)

IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. by Tingting Wang (123983)

IFA disarmed capsule-mediated immune evasion. by Tingting Wang (123983)

IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. by Tingting Wang (123983)

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. by Tingting Wang (123983)

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. by Tingting Wang (123983)

The effect of IFN-β and Vit D on the NF-κB gene expression. by Farzad Nasri (8941850)

“…Two lower concentrations of Vit D induced a reduction in the NF-κB expression compared to the control, while the highest concentration increased it significantly <b>(B)</b>. In the co-treatment groups, a dose-dependent decrease pattern among different concentration was seen in the NF-κB expression, but generally it was increased compared to the control <b>(C)</b>. …”

RICTOR regulates UGCG expression via transcription factor Zinc Finger X-linked (ZFX). by Mohammad Nafees Ansari (22232505)

“…<b>(T)</b> Tumor growth kinetics recorded a significantly higher growth of MCF-7_ZFX^OE (mean ± SEM, <i>n</i> = 4-6) than MCF-7_VECT^OE tumors. …”

Predictors in ordinal regression model for GDS. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

Classification of hand grip strength. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

Rating scale for functional severity [28]. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

Regression model coefficients. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

ICOPE screening positive participant’s responses. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

WHO BMI classification for adults. by Shane Naidoo (20148021)

“…</p><p>Results</p><p>The sample had a mean BMI of 27.53 kg/m² (95% CI [26.99, 28.07], SD = 5.49), with an obesity prevalence of 31.82%. …”

Related to Fig 1. by Mohammad Nafees Ansari (22232505)

“…(<b>E</b>–<b>H</b>) Absolute quantification (mean ± SEM, <i>n</i> = 3–4) of GM3 (E), GD3 (F), GM2 (G), and GM1 (H) gangliosides shows an increase in GD3 and GM2 gangliosides and a decrease in GM3 and GM1 gangliosides in BT-474_UGCG^OE cells compared to BT-474 cells. …”